Pentagon contract could send this $2 AI stock soaring

Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...

INZY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.88%

Insider Buying (Last 12 Months): $5,420,608.80

Insider Selling (Last 12 Months): $52,209.62

Inozyme Pharma Insider Trading History Chart

Inozyme Pharma Share Price & Price History

^$4.40

+0.30 (1.20%)

As of 04/24/2024 01:00 AM ET

Days: 30 | 90 | 365

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Inozyme Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/2/2024	Douglas A Treco	CEO	Sell	7,523	$6.94	$52,209.62	20,665
8/1/2023	Pivotal Bioventure Partners Fu	Director	Buy	833,333	$4.80	$3,999,998.40	2,923,110
5/11/2023	Robert Lorne Hopfner	Director	Buy	219,230	$6.48	$1,420,610.40	3,432,816
3/29/2023	Robert Lorne Hopfner	Director	Buy	344,592	$4.54	$1,564,447.68	3,213,586
3/27/2023	Robert Lorne Hopfner	Director	Buy	51,074	$3.70	$188,973.80	2,712,228
12/15/2022	Henric Bjorn Bjarke	COO	Buy	21,500	$1.39	$29,885.00	105,441
4/19/2022	Axel Bolte	CEO	Buy	67,750	$3.69	$249,997.50	258,575
4/19/2022	Henric Bjorn Bjarke	COO	Buy	27,100	$3.69	$99,999.00	80,626
4/19/2022	Longitude Capital Partners Iii	Major Shareholder	Buy	1,355,000	$3.69	$4,999,950.00	4,174,379
4/19/2022	Robert Lorne Hopfner	Director	Buy	1,070,000	$3.69	$3,948,300.00	2,661,154
6/24/2021	Axel Bolte	CEO	Sell	66,788	$0.00	$0.00	257,613

Pentagon contract could send this $2 AI stock soaring

From Behind the Markets | Ad

Get all the info here >>>

SEC Filings (Institutional Ownership Changes) for Inozyme Pharma (NASDAQ:INZY)

88.30% of Inozyme Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Inozyme Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/20/2024	Eventide Asset Management LLC	3,179,837	$13.55M	0.2%	+1.8%	5.149%
2/15/2024	Octagon Capital Advisors LP	400,000	$1.70M	0.3%	-69.2%	0.648%
2/14/2024	Superstring Capital Management LP	123,944	$0.53M	0.4%	N/A	0.201%
2/13/2024	Affinity Asset Advisors LLC	1,885,802	$8.03M	1.5%	+36.7%	3.053%
1/19/2024	Denali Advisors LLC	22,000	$94K	0.0%	-17.6%	0.036%
1/18/2024	Values First Advisors Inc.	13,898	$59K	0.0%	N/A	0.023%
1/12/2024	SG Americas Securities LLC	21,236	$90K	0.0%	+46.9%	0.034%
11/15/2023	Rock Springs Capital Management LP	3,681,174	$15.46M	0.4%	+7.4%	5.960%
11/15/2023	Laurion Capital Management LP	677,329	$2.85M	0.0%	+170.5%	1.097%
11/15/2023	Adage Capital Partners GP L.L.C.	5,537,500	$23.26M	0.1%	+30.3%	8.966%
11/15/2023	Affinity Asset Advisors LLC	1,379,852	$5.80M	1.6%	+83.5%	2.234%
11/14/2023	Eventide Asset Management LLC	3,125,000	$13.13M	0.2%	N/A	5.060%
11/14/2023	Schonfeld Strategic Advisors LLC	311,880	$1.31M	0.0%	+346.8%	0.505%
11/14/2023	Pivotal bioVenture Partners Investment Advisor LLC	4,494,851	$18.88M	7.5%	+22.8%	7.278%
11/13/2023	CHI Advisors LLC	1,270,027	$5.33M	1.6%	+6.3%	2.056%
11/13/2023	FMR LLC	2,465,232	$10.35M	0.0%	+229.2%	3.992%
11/7/2023	New York State Common Retirement Fund	13,375	$56K	0.0%	-21.8%	0.022%
10/26/2023	Strs Ohio	9,900	$41K	0.0%	N/A	0.016%
10/13/2023	SG Americas Securities LLC	14,452	$61K	0.0%	N/A	0.023%
9/21/2023	Barclays PLC	10,205	$56K	0.0%	+62.7%	0.017%
8/22/2023	CHI Advisors LLC	1,195,027	$6.66M	2.0%	-11.0%	1.936%
8/15/2023	Sphera Funds Management LTD.	1,131,967	$6.31M	1.0%	-36.5%	1.834%
8/14/2023	Deep Track Capital LP	1,644,021	$9.16M	0.4%	-49.4%	2.663%
8/14/2023	Rock Springs Capital Management LP	3,428,084	$19.09M	0.5%	+6.6%	5.553%
8/11/2023	Pivotal bioVenture Partners Investment Advisor LLC	3,661,518	$20.40M	6.7%	+13.9%	5.932%
8/7/2023	Acadian Asset Management LLC	57,468	$0.32M	0.0%	N/A	0.124%
8/4/2023	Parallel Advisors LLC	15,427	$86K	0.0%	-22.3%	0.033%
8/4/2023	American International Group Inc.	16,292	$91K	0.0%	N/A	0.035%
7/18/2023	Denali Advisors LLC	26,700	$0.15M	0.1%	N/A	0.061%
5/15/2023	Affinity Asset Advisors LLC	751,796	$4.31M	1.4%	+50.4%	1.718%
5/11/2023	CHI Advisors LLC	1,342,191	$7.69M	2.0%	-39.1%	3.067%
5/11/2023	Knott David M Jr	160,000	$0.92M	0.4%	N/A	0.366%
5/1/2023	Virtu Financial LLC	46,995	$0.27M	0.0%	N/A	0.107%
2/10/2023	NEA Management Company LLC	2,437,689	$2.56M	0.1%	-0.3%	6.035%
11/14/2022	UBS Oconnor LLC	165,498	$0.44M	0.0%	-3.4%	0.412%
8/16/2022	Deerfield Management Company L.P. Series C	2,696,372	$12.86M	0.3%	+15.0%	6.724%
8/15/2022	Laurion Capital Management LP	271,800	$1.30M	0.0%	+2,618.0%	0.678%
8/15/2022	Pivotal bioVenture Partners Investment Advisor LLC	2,661,154	$12.69M	6.4%	+67.2%	6.637%
8/11/2022	Bioimpact Capital LLC	664,980	$3.17M	0.9%	+125.4%	1.658%
8/11/2022	Overbrook Management Corp	69,326	$0.33M	0.1%	+314.5%	0.173%
8/8/2022	Walleye Capital LLC	101,442	$0.48M	0.0%	N/A	0.253%
2/15/2022	Laurion Capital Management LP	13,390	$91K	0.0%	-81.1%	0.057%
2/15/2022	Adage Capital Partners GP L.L.C.	1,599,028	$10.91M	0.0%	+8.9%	6.757%
2/14/2022	Suvretta Capital Management LLC	1,013,216	$6.91M	0.1%	+2.7%	4.281%
2/11/2022	Bioimpact Capital LLC	302,615	$2.06M	0.4%	-5.6%	1.279%
2/8/2022	Northern Trust Corp	120,762	$0.82M	0.0%	+4.0%	0.510%
2/2/2022	New York State Common Retirement Fund	3,834	$26K	0.0%	-63.3%	0.016%
11/16/2021	Suvretta Capital Management LLC	986,400	$11.43M	0.2%	+170.1%	4.168%
11/16/2021	Wellington Management Group LLP	364,600	$4.23M	0.0%	-50.0%	1.541%
11/16/2021	Laurion Capital Management LP	70,700	$0.82M	0.0%	N/A	0.299%
11/16/2021	BioImpact Capital LLC	320,724	$3.72M	0.6%	N/A	1.355%
11/16/2021	CHI Advisors LLC	920,264	$10.67M	3.1%	-0.8%	3.889%
11/15/2021	Deerfield Management Company L.P. Series C	2,344,786	$27.18M	0.5%	+7.6%	9.910%
11/15/2021	Rock Springs Capital Management LP	850,015	$9.85M	0.2%	+1.2%	3.592%
11/15/2021	Marshall Wace LLP	33,408	$0.39M	0.0%	-16.9%	0.141%
11/15/2021	Caas Capital Management LP	135,398	$1.57M	0.0%	N/A	0.572%
11/12/2021	Geode Capital Management LLC	198,624	$2.30M	0.0%	+10.5%	0.839%
11/8/2021	Russell Investments Group Ltd.	115,516	$1.34M	0.0%	+4,518.8%	0.488%
11/2/2021	New York State Common Retirement Fund	10,453	$0.12M	0.0%	+18.8%	0.044%
11/1/2021	SG Americas Securities LLC	11,611	$0.14M	0.0%	N/A	0.049%
8/25/2021	Marshall Wace LLP	40,202	$0.69M	0.0%	-22.4%	0.170%
8/17/2021	Millennium Management LLC	61,313	$1.05M	0.0%	-58.9%	0.259%
8/17/2021	Burrage Capital Management LLC	242,517	$4.13M	4.1%	+43.1%	1.025%
8/17/2021	Citadel Advisors LLC	171,066	$2.92M	0.0%	-28.8%	0.723%
8/16/2021	California State Teachers Retirement System	19,867	$0.34M	0.0%	+9.5%	0.084%
8/16/2021	Charles Schwab Investment Management Inc.	61,917	$1.06M	0.0%	+4.1%	0.262%
8/16/2021	State Street Corp	169,889	$2.90M	0.0%	+28.5%	0.718%
8/16/2021	Nuveen Asset Management LLC	47,394	$0.81M	0.0%	+122.6%	0.200%
8/16/2021	Goldman Sachs Group Inc.	19,310	$0.33M	0.0%	-18.8%	0.082%
8/16/2021	Marshall Wace LLP	40,202	$0.69M	0.0%	-22.4%	0.170%
8/13/2021	Northern Trust Corp	120,743	$2.06M	0.0%	+4.6%	0.514%
8/13/2021	Geode Capital Management LLC	179,672	$3.06M	0.0%	+19.5%	0.765%
8/13/2021	Vanguard Group Inc.	335,286	$5.71M	0.0%	-1.7%	1.428%
8/12/2021	JPMorgan Chase & Co.	16,659	$0.28M	0.0%	-21.9%	0.071%
8/11/2021	Bank of New York Mellon Corp	36,546	$0.62M	0.0%	+56.6%	0.156%
8/11/2021	BlackRock Inc.	899,873	$15.34M	0.0%	+4.4%	3.832%
8/10/2021	Citigroup Inc.	2,108	$36K	0.0%	+69.3%	0.009%
8/5/2021	Rhumbline Advisers	12,787	$0.22M	0.0%	N/A	0.054%
8/4/2021	Russell Investments Group Ltd.	2,501	$42K	0.0%	N/A	0.011%
8/2/2021	New York State Common Retirement Fund	8,802	$0.15M	0.0%	-28.4%	0.037%
5/18/2021	Millennium Management LLC	149,205	$2.95M	0.0%	N/A	0.635%
5/18/2021	Citadel Advisors LLC	240,401	$4.76M	0.0%	-4.8%	1.024%
5/18/2021	California State Teachers Retirement System	18,143	$0.36M	0.0%	+47.5%	0.077%
5/17/2021	Deerfield Management Company L.P. Series C	1,964,000	$38.89M	0.8%	+70.7%	8.363%
5/17/2021	Rock Springs Capital Management LP	827,900	$16.39M	0.4%	-0.3%	3.526%
5/17/2021	Suvretta Capital Management LLC	341,427	$6.76M	0.1%	+59.3%	1.454%
5/17/2021	Caas Capital Management LP	177,502	$3.52M	0.0%	N/A	0.756%
5/17/2021	Novo Holdings A S	1,969,379	$38.99M	1.6%	-23.4%	8.386%
5/17/2021	Goldman Sachs Group Inc.	23,790	$0.47M	0.0%	+14.2%	0.101%
5/13/2021	Bank of New York Mellon Corp	23,337	$0.46M	0.0%	+9.3%	0.099%
5/13/2021	Citigroup Inc.	1,245	$25K	0.0%	-44.3%	0.005%
5/12/2021	Northern Trust Corp	115,469	$2.29M	0.0%	+24.4%	0.492%
5/12/2021	Geode Capital Management LLC	150,361	$2.98M	0.0%	+41.3%	0.641%
5/12/2021	JPMorgan Chase & Co.	21,324	$0.42M	0.0%	+455.9%	0.091%
5/11/2021	New York State Common Retirement Fund	12,300	$0.24M	0.0%	+66.2%	0.052%
5/7/2021	BlackRock Inc.	861,683	$17.06M	0.0%	+36.6%	3.671%
5/7/2021	American International Group Inc.	7,011	$0.14M	0.0%	+48.4%	0.030%
5/4/2021	Commonwealth Equity Services LLC	65,781	$1.30M	0.0%	N/A	0.280%
3/12/2021	DekaBank Deutsche Girozentrale	7,000	$0.17M	0.0%	N/A	0.030%
2/19/2021	JPMorgan Chase & Co.	3,836	$79K	0.0%	+26.6%	0.016%

Data available starting January 2016

Inozyme Pharma, Inc., a clinical-stage rare disease biopharmaceutical company, focuses on developing novel therapeutics for the treatment of vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant, genetically engineered, and fusion protein for the treatment of ENPP1 and ABCC6 deficiencies, as well as patients with end-stage kidney disease receiving hemodialysis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $4.40

$4.35

$4.49

50 Day Range

MA: $5.92

$4.39

$7.66

52 Week Range

Now: $4.40

$2.69

$7.80

Volume

478,912 shs

Average Volume

618,463 shs

Market Capitalization

$271.79 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.37

Who are the company insiders with the largest holdings of Inozyme Pharma?: Inozyme Pharma's top insider investors include:
Robert Lorne Hopfner (Director)
Pivotal Bioventure Partners Fu (Director)
Henric Bjorn Bjarke (COO)
Douglas A Treco (CEO)
Learn More about top insider investors at Inozyme Pharma.

Pentagon contract could send this $2 AI stock soaring

From Behind the Markets | Ad

Get all the info here >>>

INZY Insider Trading

Inozyme Pharma Insider Trading History Chart

Inozyme Pharma Share Price & Price History

Inozyme Pharma Insider Trading History

SEC Filings (Institutional Ownership Changes) for Inozyme Pharma (NASDAQ:INZY)

Institutional Buying and Selling by Quarter

Inozyme Pharma Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Inozyme Pharma?